RESPIRONICS
BioRexis is a biopharmaceutical company. It develops and produces biopharmaceuticals. BioRexis offers protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company’s products include peptide fusion, which is used for the treatment of type 2 diabetes. It also provides biopharmaceutical products for longer-acting interferon and an erythropoietin receptor agonist. The company was founded in 2002 and is based in King of Prussia, Pennsylvania. It operates as a subsidiary of Pfizer.
RESPIRONICS
Industry:
Biopharma Health Care Medical
Founded:
1976-01-01
Address:
Murrysville, Pennsylvania, United States
Country:
United States
Status:
Active
Similar Organizations
Barrier Therapeutics
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.
ENDOGENX
Endogenx is a global pharmaceutical and drug development company based in the United States.
Mezzion
Mezzion is a pharmaceuticals company that develops and discovers medicines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Founder
